BIOMAT Database Logo BIOMAT Database Logo

The treatment of hemochromatosis by phlebotomy. 1966

L R Weintraub, and M E Conrad, and W H Crosby

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001815 Bloodletting Puncture of a vein to draw blood for therapeutic purposes. Bloodletting therapy has been used in Talmudic and Indian medicine since the medieval time, and was still practiced widely in the 18th and 19th centuries. Its modern counterpart is PHLEBOTOMY.
D006432 Hemochromatosis A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed) Diabetes, Bronze,Bronze Diabetes,Bronzed Cirrhosis,Familial Hemochromatosis,Genetic Hemochromatosis,Haemochromatosis,Hemochromatoses,Iron Storage Disorder,Pigmentary Cirrhosis,Primary Hemochromatosis,Troisier-Hanot-Chauffard Syndrome,Von Recklenhausen-Applebaum Disease,Bronzed Cirrhoses,Cirrhoses, Bronzed,Cirrhoses, Pigmentary,Cirrhosis, Bronzed,Cirrhosis, Pigmentary,Disease, Von Recklenhausen-Applebaum,Diseases, Von Recklenhausen-Applebaum,Disorder, Iron Storage,Disorders, Iron Storage,Familial Hemochromatoses,Genetic Hemochromatoses,Haemochromatoses,Hemochromatose,Hemochromatoses, Familial,Hemochromatoses, Genetic,Hemochromatosis, Familial,Hemochromatosis, Genetic,Iron Storage Disorders,Pigmentary Cirrhoses,Recklenhausen-Applebaum Disease, Von,Recklenhausen-Applebaum Diseases, Von,Storage Disorder, Iron,Storage Disorders, Iron,Syndrome, Troisier-Hanot-Chauffard,Syndromes, Troisier-Hanot-Chauffard,Troisier Hanot Chauffard Syndrome,Troisier-Hanot-Chauffard Syndromes,Von Recklenhausen Applebaum Disease,Von Recklenhausen-Applebaum Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L R Weintraub, and M E Conrad, and W H Crosby
The treatment of idiopathic hemochromatosis by repeated phlebotomy.
May 1953, Annals of internal medicine,
L R Weintraub, and M E Conrad, and W H Crosby
[Cardiac hemochromatosis: a potentially reversible myocardiopathy with chronic treatment by phlebotomy].
May 1987, Medicina clinica,
L R Weintraub, and M E Conrad, and W H Crosby
Hereditary hemochromatosis: patient experiences of the disease and phlebotomy treatment.
June 2011, Transfusion,
L R Weintraub, and M E Conrad, and W H Crosby
Treatment of hemochromatosis with phlebotomy of 35,000 cc. of blood.
December 1957, New York state journal of medicine,
L R Weintraub, and M E Conrad, and W H Crosby
Idiopathic hemochromatosis: serum ferritin concentrations during therapy by phlebotomy.
August 1982, Clinical chemistry,
L R Weintraub, and M E Conrad, and W H Crosby
Phlebotomy, blood donation, and hereditary hemochromatosis.
April 2001, Transfusion medicine reviews,
L R Weintraub, and M E Conrad, and W H Crosby
Phlebotomy increases cadmium uptake in hemochromatosis.
April 2000, Environmental health perspectives,
L R Weintraub, and M E Conrad, and W H Crosby
A history of phlebotomy therapy for hemochromatosis.
January 1991, The American journal of the medical sciences,
L R Weintraub, and M E Conrad, and W H Crosby
Influence of phlebotomy treatment on abnormal hypothalamic-pituitary function in genetic hemochromatosis.
June 1987, Mayo Clinic proceedings,
L R Weintraub, and M E Conrad, and W H Crosby
A survey of phlebotomy among persons with hemochromatosis.
June 1999, Transfusion,
Copied contents to your clipboard!